chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Mild to medium voice hoarseness. It has been continuous since vaccine 1 even with vocal rest and nutrients/nourishment. I have not yet visited a doctor but will reach out now.
I had chills, fever 104, body aches, sneezing, and severe cough. I took TYLENOL and it didn't help with my fever. I tested positive for COVID-19. I called the physician, and they prescribe me PAXLOVID. Around 02/22/2023 I started to feel better. The next day I got worse with the same symptoms. I went to the doctor, and she did a chest x-ray and found bronchitis and pneumonia. She prescribed me an albuterol inhaler and LEVAQUIN. I was still testing positive for COVID-19 on 03/06/2023. I finally tested negative on 03/11/2023. I am still congested, coughing, and exhausted.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 069H21A) for COVID-19 vaccination.    Co-suspect product included non-company product INFLUENZA VACCINE (FLU) for an unknown indication.    No Medical History information was reported.   On 21-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and dose of INFLUENZA VACCINE (FLU) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   This case was linked to MOD-2022-455441 (Patient Link).
Cloudy Thinking; Tight chest; light headed from vaccine; stomach ache; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach ache), FEELING ABNORMAL (Cloudy Thinking), CHEST DISCOMFORT (Tight chest) and DIZZINESS (light headed from vaccine) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 042L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach ache). On an unknown date, the patient experienced FEELING ABNORMAL (Cloudy Thinking), CHEST DISCOMFORT (Tight chest) and DIZZINESS (light headed from vaccine). At the time of the report, ABDOMINAL PAIN UPPER (stomach ache), FEELING ABNORMAL (Cloudy Thinking), CHEST DISCOMFORT (Tight chest) and DIZZINESS (light headed from vaccine) outcome was unknown. Not Provided          No relevant concomitant medications were reported. No treatment information was provided.
This spontaneous report was received from a healthcare worker concerning to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 15-MAY-2017, the patient was vaccinated with an improperly stored ROTATEQ dose, orally for prophylaxis (the lot #, expiration date, strength, and frequency were not provided). The stored conditions were reported as follow: temperature: 32 Fahrenheit degrees to 35 Fahrenheit degrees, for a period of 24 hours. There was not previous temperature excursion reported. A data logger was reported. Additional information has been requested.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. The patient's medical history and current conditions were not provided. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiration date, dose and route were not reported). Secondary suspects and concomitant therapies were not reported. On an unknown date, the patient experienced herpes sine herpete following administration of ZOSTAVAX. The outcome of adverse event was unknown. The relatedness between adverse event and ZOSTAVAX was not reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient worked night shift, receive vaccine in AM at end of shift, went home and slept well, returned to work same day with symptoms progressively worsening that had started at 6:00 p.m. Patient describes symptoms as 'severe headache, nausea, stiff neck, arm tingling, hands hot, feet freezing'. Sent to MD. BP was 130/100. Temp 98.7F Treated for headache.
pt recvd vax; red, swollen, erythema for 72 hrs; Rt deltoid swelling down to 1-2" above elbow;
He fainted, became sweaty. Recovered in about 10 minutes after drinking a bottle of water.
Given expired covid 19 vaccines: Expired 10/25/2022. Given 03/17/2023
Muscle spasms throughout the body (leg, thigh, arm, stomach); This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 08Sep2021 04:00 (Lot number: FL3184) at the age of 34 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: ELDERBERRY EXTRACT; VITAMIN D [VITAMIN D NOS]. The following information was reported: MUSCLE SPASMS (non-serious) with onset 15Sep2021 22:00, outcome "not recovered", described as "Muscle spasms throughout the body (leg, thigh, arm, stomach)". The event "muscle spasms throughout the body (leg, thigh, arm, stomach)" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of muscle spasms. Additional information: No other vaccine was given in four weeks. Other medications in two weeks included Women's Daily multi-vitamin, Elderberry, Vitamin D.Treatment prescribed was muscle relaxer & blood work for event Muscle spasms. Patient did not have Covid prior to vaccination. Covid was not tested post vaccination No known allergies were reported.  Follow-up attempts are completed. No further information is expected.
Vaccine administered 12/29/2021. Reports of itching and dyspnea. Treated with Benadryl 50mg  which improved symptoms. Reports of dyspnea, cough, SOB, and itching on abdomen, chest, back, and neck persisting  on 12/30/21 and appointment made at MD office.  MD treated with Duoneb nebs, Benadryl 25mg PO, and prednisone 20mg daily x5 days ordered. Symptoms improved. Ruled out  PE/DVT.
flu like symptoms; feeling sick; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose year ago from time of reporting).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced influenza-like symptoms and feeling unwell. On an unknown date, the outcome of the influenza-like symptoms was resolved with sequelae and the outcome of the feeling unwell was recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms and feeling unwell to be related to Shingrix.  Additional details were provided as follows: The case was reported by the reporter for her cousin was around 70 years old. The age at vaccination was not reported. The patient felt sick like she had the flu after the 2nd dose. This is 1 of the 3 cases reported by same reporter.
Hives - face area - night after shot Chills - day after. Sore throat, chest congestion - coughing. SOB - chest discomfort - ER adm. 1/17/12. Albuterol inh. IV fluids.
nausea; weakness; anaphylaxis /  admitted / treated for anaphylaxis; itching / still experiencing some itching/itching became worse; This case was reported by a consumer via call center representative and described the occurrence of anaphylaxis in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th July 2020, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 31st July 2020, 2 days after receiving Shingrix, the patient experienced anaphylaxis (serious criteria hospitalization and GSK medically significant) and pruritus (serious criteria hospitalization). On 1st August 2020, the patient experienced nausea (serious criteria hospitalization) and weakness (serious criteria hospitalization). On 10th September 2020, the outcome of the anaphylaxis, nausea and weakness were recovered/resolved. On an unknown date, the outcome of the pruritus was not recovered/not resolved.   The reporter considered the anaphylaxis, pruritus, nausea and weakness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix in left arm. 2 days after receiving Shingrix, the patient began to developed anaphylaxis with itching. The day after that (3 days later), the itching became worse and the patient also started to experienced nausea and weakness. The patient was taken to the hospital where she was admitted for 3 days and treated for anaphylaxis.  The patient's symptoms had resolved except she still experiencing some itching at the time of reporting.  The reporter consented to follow up.
8mins post vaccination pt c/o dizziness. Vitals: 137/91, 66, 20 Pt stable and released from vaccination site w/ mother.
Patient has a history of bilateral lower extremity ulcers but is adamant about them getting worse after he received the Covid19 vaccine (dose 1 02/09/2021 and dose 2 04/13/2021).
pt recvd vax; pt seen by MD w/ neck pain & neck stiffness;
Day after receiving vaccine: fatigue, fever, headache, body aches, shortness of breath,  Two days after receiving vaccine: extreme fatigue, racing pulse, high blood pressure
After I took this vaccine I started experience tendinosis in both my ears. This problem is still ongoing. I have visited my ears nose and throat doctor and confirmed that my hearing is fine, as well as have had wax removal. I can hear just fine however it feels like its always ringing just really low.
massive pulmonary embolism; This is a spontaneous report received from contactable reporter (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A 37 -old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 09Apr2021 (Lot number: EW0158) at the age of 37 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Depression" (unspecified if ongoing). Concomitant medications included: JUNEL FE 1.5/30 taken for contraception, stop date: 04Dec2021; ZOLOFT ODT taken for depression, start date: Apr2021 (ongoing).  The following information was reported: PULMONARY EMBOLISM (hospitalization, life threatening, medically significant) with onset 12Apr2021, outcome "recovering", described as "massive pulmonary embolism". The patient was hospitalized for pulmonary embolism (start date: 12Apr2021, discharge date: 12Jun2021, hospitalization duration: 61 day(s)). The event "massive pulmonary embolism" was evaluated at the physician office visit and emergency room visit. Therapeutic measures were taken as a result of pulmonary embolism. Patient was taking treatment drug Lovenox 2x/day.  No follow-up attempts are possible. No further information is expected.  Follow-Up (16DEC2021): Follow-up attempts are completed. No further information is expected.
11/21 and 11/22-headache, stiff neck, low grade fever; 11/23 felt fatigued, neck and back pain; 11/24 "night sweats"-joints ached, felt warm and knees became swollen. Temp 101.5; 11/26 difficulty walking-went to emergency room. Treated with IV fluid and anti- flammatory med. Discharged with Doxyclyine and Naprocyn; 11/28 went to primary care physician-had urinary tract infection, given Cipro and cortisone shot; 12/1 inflammation decreased and saw a rheumatologist. Blood work drawn.
Onset of dry cough and chest tightness ~48 hours later; delayed diagnosis of acute pulmonary embolus confirmed 4/29/21
Hives  w/"itchiness" approx. 15 minutes after administration; resolved after Pt took Benadril
at  24 hours after injection: arm soreness, extremely tiered, chills chills lasted 8 hours continue to be tiered arm no longer sore
The patient did not have a reaction. The patient was given her first dose on 12-29-2020 and inadvertently given the 2nd dose 1-13-2021. The patient was monitored >20 min with no complications.
This spontaneous report was received from a registered nurse referring to a 8-month old patient of unknown gender. The patient's pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not provided. On unknown dates, the patient was vaccinated with improperly stored doses of ROTATEQ, orally, lot # N021308, expiration date 05-MAR-2019 (strength, dose, frequency and anatomical location were not reported) for prophylaxis. The vaccines were reconstituted with properly stored sterile diluent. There was no adverse effect reported. The administered doses of vaccines experienced the temperature excursion of 9 to 25 (8.6) degrees Celsius for 16 minutes. Data logger was involved. There were no previous excursions reported. This report was not associated with a product quality complaint. This is one of several reports with the same reporter.
Became more restless and tired at the same time.  His poop was extremely "toxic" we had to change him within seconds of bowel movement, otherwise he would get blisters on his bottom.  Started regressing and lost speech later diagnosed with Autism.
Pt recv vax on 9/21/98; on 9/25/98 pt exp seizure for 1 min.  Pt hosp for 2 days.
Case number PHEH20143US011039 is an initial spontaneous report received from a physician on 16 MAY 2013 and a follow up report from the consumer (patients mother) received on 14 JUN 2013. This case refers to an 18-year-old male patient. His medical history included allergies (unspecified). His vaccination history included vaccination with DTap (other manufacturer) on 28 NOV 1994, 10 FEB 1995, 15 MAR 1995, 02 MAY 1996 and on 01 MAY 2000, TDap  (other manufacturer) on 16 AUG 2007, polio (unknown manufacturer, batch number: not reported) (refer to case: PHHYY013US061999), HIB (unknown manufacturer, batch number: not reported) on 28 NOV 1994, on 10 FEB 1995, on 16 MAR 1995 and on 07 FEB 1996, MMR (other manufacturer) on 07 FEB 1996 and on 01 MAY 2000, hepatitis B (other manufacturer) on 28 NOV 1995, on 10 FEB 1995, and on 15 SEP 1995, varicella (other manufacturer) on 15 SEP 1995 and on 28 JAN 2009 and complete immunization with pneumonia conjugate (other manufacturer) on an unknown date. He was vaccinated with MENVEO (batch number: A12118) intramuscularly at left deltoid on 15 MAY 2013 at a dose of 0.5 ml. On the same day, after vaccination he experienced pain at site, body aches, skin tingling, headache and fatigue. The final outcome was reported as recovered on an unknown date. The seriousness and causality were not reported. The patient transferred his records and so no follow date available.   Follow up report from the consumer (patients mother) received on 14 JUN 2013: Vaccination history and event (pain at site) were added. The MENVEO details (dose and site of vaccination) and outcome of the events were updated.
A report received from a health care professional on 11/13/2002, concerning a 48 year old male vaccinee who experienced an erythematous maculo-papular rash, low grade fever and myalgia 4 days after receiving Fluvirin on 11/08/02. On 11/12/02, the vaccinee experienced an erythematous maculo-papular rash, low grade fever and myalgia 4 days after receiving Fluvirin. The erythematous maculo-papular rash developed all over his body. The vaccinee was treated with Tylenol and Benadryl (OTC strength). At the time of reporting the vaccinee had not yet recovered. The reporter has assessed the relationship of the vaccine to the event as probable and that the vaccinee experienced a hypersensitivity to Fluvirin.
Underarm swollen/Is it normal for the arm you receive shot to swell under the arm; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE SWELLING (Underarm swollen/Is it normal for the arm you receive shot to swell under the arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Underarm swollen/Is it normal for the arm you receive shot to swell under the arm). At the time of the report, VACCINATION SITE SWELLING (Underarm swollen/Is it normal for the arm you receive shot to swell under the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medication details were reported.
No adverse event noted. Vaccine given more than 12 hrs after vial was punctured.
After vaccine, pt. lay down on bed, straightened legs, according to Mom, had "bubbling" around her mouth. Mom called out, as soon as 1(nurse) came in the, pt. was talking, with eyes open.
Since April 20th, I have had chest compression pain, raising heartbeat, difficulty breathing, severe pain in chest, throat, and face
A few hours after the vaccination patients left arm got red, painful and swollen. After 24 hours it seemed worse and the redness had spread down to her forearm. Patient spoke to her doctor and they prescribed azithromycin (500mg on day 1 and 250 mg on days 2-5) in case this was cellulitis. As of 8/13 her arm is improving but still has some swelling.
pt recvd vax; weakness affecting both upper & lower extremities, compatible w/ GBS;
Full body rash about 2 hrs after vaccine administration. No shortness of breath. Pt. referred to ER. Treatment unknown.
Information has been received from a 22 year old female patient with allergy reaction from to antibiotic, who on 30-JUN-2008 was vaccinated with the first dose of GARDASIL. On approximately 24-SEP-2008, the patient received her second dose of GARDASIL. There was no concomitant medications. On 28-SEP-2008, the patient woke up with stuffy nose, cough, fever, and general body aches. The patient did mention that her family recently had suffered from cold symptoms as well and she may have picked it from them. She did not had a similar reaction after the first dose of GARDASIL. The patient also stated that her arm was still a little sore. The patient sought unspecified medical attention. At the time of the report the patient had not recovered. No further information is expected.
More pain; Blood pressure was so high because patient was upset; Blood pressure was so high because patient was upset; Diarrhea; Nauseated; Bump on the reaction site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (More pain), HYPERTENSION (Blood pressure was so high because patient was upset), EMOTIONAL DISTRESS (Blood pressure was so high because patient was upset), DIARRHOEA (Diarrhea) and NAUSEA (Nauseated) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis (Moderate to severe rheumatoid arthritis).   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (More pain), HYPERTENSION (Blood pressure was so high because patient was upset), EMOTIONAL DISTRESS (Blood pressure was so high because patient was upset), DIARRHOEA (Diarrhea), NAUSEA (Nauseated) and INJECTION SITE PAPULE (Bump on the reaction site). At the time of the report, PAIN (More pain), HYPERTENSION (Blood pressure was so high because patient was upset) and EMOTIONAL DISTRESS (Blood pressure was so high because patient was upset) outcome was unknown and DIARRHOEA (Diarrhea), NAUSEA (Nauseated) and INJECTION SITE PAPULE (Bump on the reaction site) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: High. On an unknown date, Blood pressure measurement: High. On an unknown date, Blood triglycerides: High.         No concomitant medication was reported. No treatment medication was reported.  Latest Moderna vaccine was booster vaccine.  It was unknown if patient was enrolled in a COVID-19 vaccine trial.  The reporter's causality for the events of more pain, nauseated, diarrhea, bump on the reaction site, blood pressure was so high because patient was upset, high sugar and high triglycerides was not provided for Humira.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Severe swelling and pain of right knee, unable to wear slacks. Swelling of right ankle. Pain in left elbow.Swelling and pain in right and left wrists. Steroid injection in right knee Dec 8. Nov 23 1 round of prednisone burst 10 mg, starting second round Dec 16. Still having pain in elbow, swelling in right knee and right ankle.
Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 26-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A and 028L20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (2 drinks, 3 times a week.) on 25-Dec-2020. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 25-Dec-2020 and the estimated date of delivery was 01-Oct-2021. On 04-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  first week of the pregnancy.  On 01-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jan-2021, Pregnancy test: positive (Positive) Positive. On 13-May-2021, Ultrasound scan: normal (normal) Normal 20 week anatomy ultrasound.         No treatment medications were provided by the reporter.  Action taken with mRNA-1273 in response to the events were Not Applicable.   Estimated date of conception was 08 Jan 2021.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Added second dose information.